Boehringer Ingelheim's Ben Venue Laboratories Bedford, Ohio, facility will no be able to manufacture and distribute drugs until the FDA determines that its operations are compliant with the Federal Food, Drug, and Cosmetic Act.
Thomson Reuters
Tuesday, 5 February 2013
Ben Venue restrained from manufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment